Respiratory / Inflammation
Dr. Lars-Göran Carlsson is the TFS Medical Scientific Advisor in Respiratory Diseases in drug development since 2013.
Dr. Carlsson was previously employed in AstraZeneca, as Medical Science Director overseeing different projects since 1998 in both early and late phases. Before leaving in 2012, his medical scientific responsibility encompassed the marketing of all respiratory products including Symbicort®. Dr. Carlsson has clinical experience in drug development of corticosteroids and bronchodilators in both oral and different inhaled formulations from the USA, Europe and Japan.
Dr. Carlsson holds a speciality certificate in both Thoracic and Internal Medicine and has a Diploma in pharmaceutical medicine from the University of Basel. He is a part-time Consultant in respiratory medicine in the Department of Respiratory Medicine and Allergy at the University Hospital of Malmö, Sweden.